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Dhis series the patients were younger and presented with
ower mean cardiothoracic ratios than in the series of Chau-
aud and colleagues.15
The Danielson operation, despite some technical mod-
fications, remains highly associated with the need for
VR. Kiziltan and coworkers4 reviewed their series of
23 patients with Ebstein’s anomaly, with TVR per-
ormed in 158 (48.9%) patients. In regard to long-term
esults, they found that the freedom from bioprosthesis
eplacement was 97.5%  1.9% after 5 years and 80.6%
7.6% after 10 years. They also found no statistically
ignificant difference at 10 and 12 years in freedom from
eoperation after TVR compared with freedom from re-
peration after TV repair. These good results, according
o the authors, might be related to the large size of
ioprosthesis that can be implanted relative to patient
omatic size and to the normally low right ventricular
ystolic pressure in patients after Ebstein’s anomaly re-
air. However, these results are for a limited period and
o not rule out the ultimate need for tricuspid prosthesis
eplacement and therefore do not decrease the importance
f creating an efficient and durable TV repair operation.
The indications for surgical intervention in patients
ith Ebstein’s anomaly remain controversial in asymp-
omatic patients, although the natural history of the dis-
ase is a relentless progression to congestive heart fail-
re, arrhythmias, or both16,17 in the majority of patients
ot undergoing operations. Mortality for these late-stage
omplications is high.18,19 It seems also to be true that
urgical treatment at late stages has less chance of re-
ersing the ravages of the disease completely. That might
e the case in 1 early death and another late progression
o heart failure in this series. These events seem to be
elated to the state of the 2 patients who had left ventric-
lar myocardiopathy preoperatively rather than to the
urgical technique. This further reinforces the notion that
urgical intervention should come earlier, before deteri-
ration of right and left ventricular function.
In conclusion, this surgical technique that reconstructs
he TV in a cone shape, which results in a central flow
hrough the tricuspid orifice and a full coaptation of the
eaflets, can be performed with low mortality and morbidity.
arly echocardiography showed significant reduction in tri-
uspid insufficiency, and the follow-up showed clinical
mprovement in the majority of patients, low incidence of
eoperations, and no need for TVR. Further studies and
onger follow-up are required to evaluate the behavior of the
V and RV after this procedure.
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iscussion
r Jan M. Quaegebeur (New York, NY). Dr da Silva, I would like
o congratulate you on the presentation of an ingenious technique.
t is interesting to note that although Ebstein’s anomaly is a very
are condition, there have been 3 presentations dedicated to this
nomaly in this meeting. Therefore the quest for a better repair of
bstein’s anomaly continues. You have described your experience
ver 10 to 12 years with an innovative technique, which tries to
mprove TV function by realizing a complete coaptation between
alvular tissue in comparison or in contrast with the previous
epairs by all of us that relied on a monocuspid or bicuspid valve
here the coaptation is between the valve leaflets, namely the
nterior and posterior leaflets, and the ventricular septum. Forty
atients were presented with a low early mortality rate and only 1
ate death, which are very good results.
and Cardiovascular Surgery ● Volume 133, Number 1 221
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DI am not entirely clear about the age of your patients. You said
hat the mean age was 16.8 years, but I would like it if you could
nswer briefly how many patients were less than 10 years of age,
or instance.
Dr da Silva. Well, the youngest in this series was 22 months
ld, and the oldest, I think, was 49 years old. Afterward, we had
ore patients, and among them there was a 3-month-old girl who
nderwent repair with this technique.
I will say that we have 16 patients younger than 13 years.
herefore 24 patients were older than that age. But I think it is
etter to use this technique in younger patients, especially those
ess than 18 years of age.
Dr Quaegebeur. You have provided me with the article and
eautiful illustrations, I must say. It happens that last week I had
patient on the schedule with Ebstein’s anomaly, and therefore I
aid, well, we will see how we can maybe improve the technique
ecause, theoretically, it would be better to have coaptation be-
ween leaflet tissue than with leaflet tissue and septal tissue.
nvariably, in our experience the residual tricuspid incompetence is
t the level at which you have absent leaflet tissue. Therefore the
oncept, I think, is very sound.
This patient had muscularization of the posterior leaflets, which
appens quite often. There was absolutely no leaflet tissue at the
evel of the septum. You have described the attachment of the
nterior leaflet at the level of the anteroseptal commissure like a bit
f fibrous continuity before it reaches the papillary muscle of the
nterior leaflet. This patient did not have such an attachment. In
y experience, I could not perform this technique.
There is a great variability in the morphology of the valve in
bstein’s malformation. My question is this: Are you always able
o perform this technique, or are there patients in whom you do
omething different?
Dr da Silva. Well, in the type D of Carpentier’s classification,
think we have to go to valve replacement. I also think that in
lder patients, if you have difficulty finding tissue enough to
onstruct a good tricuspid valve, it is good to indicate valve
eplacement or the Carpentier or other repair technique if possible.
ut in my experience, all cases were done with this technique. If
ou push to it, you can do a lot of maneuvers that can compensate
or having little tissue. One of them is to take down the posterior
eaflet from its attachment without support and then get the support
or that leaflet at the septal tissues. You can have some residual,
alformed septal leaflet that can be useful as a subvalvular support
or the posterior leaflet. And with that I think you can reconstruct
he cone the way I did many times. Actually, I have movies on
hose patients, in many situations, that can be handed to people if
hey want; they show many variations of the technique. Anyway,
agree that in complex situations sometimes it might be better to
eplace the valve.
Dr Quaegebeur. The next question is with regard to your
chocardiographic evaluation. The distance between the postero-
eptal commissure and the anteroseptal commissure in patients
ith Ebstein’s anomaly is sometimes quite large. Now the reduc-
ion of the tricuspid annulus is mainly done in the part where you
ave a very thin atrialized portion of the right ventricle. The area
f the septum is very difficult to plicate. Therefore if you have to
ring the posterior leaflet back to the anteroseptal commissure, you
eally have to reduce the annulus posteriorly quite significantly. t
22 The Journal of Thoracic and Cardiovascular Surgery ● JanuThe question is this: Do you have any data about the tricuspid
nnulus postoperatively compared with during the normal disease
ourse in terms of the possibility of creating an atrial cuspid
nnulus that is too small?
Dr da Silva. Well, we have done echocardiography on the
ospital discharge day, usually on the 10th postoperative day, and
e have measurement of that annulus. Actually, there is a reduc-
ion of its anteroposterior diameter of about 50%, compared with
he preoperative diameter.
Now regarding the z score, we do not have those data, but we
ave compared with the mitral annulus.
Right now, we are in the process of re-evaluating these patients.
f you take the first girl on whom we operated, she required
eoperation. But now, 13 years from the operation, her tricuspid
nnulus is already greater than the mitral valve.
We had 2 cases in which we had gradient across the TV that
as concerning to me, but then with time the annulus had grown,
nd that gradient went away.
Importantly, we did not have any case of permanent tricuspid
tenosis. But I think that is a good idea. We have all the cases being
tudied, and we still can compare with the normal z score for sure.
Dr Quaegebeur. Finally, you have a few patients in whom you
ave had to reintervene because of failure. Do you know the mode
f failure? What happened to these reconstructions?
Dr da Silva. Thank you for yours remarks and questions.
egarding the reoperations, the first girl of this series had dehis-
ence in the septal area of the valve. Another patient who had
olff-Parkinson-White syndrome came back with a tear in the
alve. We usually try to cut the abnormal accessory pathway
urgically, but in that case we could not accomplish that, and the
atient underwent many sessions of catheterization, trying to do
atheter ablation of that abnormal conduction pathway.
Recently, a month ago, we had to reoperate on another patient;
he first operation was done 20 years ago, when he was 7 years old.
gain, there was a dehiscence at the level of the septum. Therefore
ecause of that concern, we are now placing at least 8 stay sutures
hat are interrupted. Then we run around the annulus, reinforcing
t with a medium-term absorbable suture. We are concerned about
hose types of dehiscence, which are very possible.
Dr Joseph A. Dearani (Rochester, Minn). I think Dr Quaegebeur
ointed out a number of important points, and the most important one
s that every patient with Ebstein’s anomaly is different. We have seen
any patients with Ebstein’s anomaly over the years, and I have
earned a lot from all of the techniques that have been described. I
hink the lesson and the message for surgeons who see patients with
bstein’s anomaly is to remember the value of these various repair
echniques and then incorporate aspects of different repairs when you
re confronted with a particular situation.
I have learned from my practice over the years that a severely
ilated right ventricle on the other side of a tricuspid repair can
ompromise the integrity and durability of that repair over time.
here have been situations where the postbypass transesophageal
chocardiogram looks very good in the operating room, and then
or 7 days later, the dismissal echocardiogram shows a greater
egree of tricuspid regurgitation. You are then confronted with the
ituation of deciding whether to accept it and know that they are
oing to be back sooner than you would like or whether you return
o the operating room to revise the repair or replace the valve. An
ary 2007
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da Silva et al Surgery for Congenital Heart Diseasemportant adjunct to the operation that I have started to do was
ntroduced by Dr Sano. This involves resecting a portion of the RV
o reduce its size. I now resect the inferior wall of the RV between
he acute margin and the posterior descending coronary artery andThe Journal of Thoracicnary artery compromise is eliminated or minimized. I think
nything to reduce the size of the large atrialized RV on the other
ide of the tricuspid repair will help in the long term. I congratulate
ou and the authors and look forward to the opportunity to applyCH
Darallel to the right coronary arterial branches, and therefore cor- some of your techniques.and Cardiovascular Surgery ● Volume 133, Number 1 223
